Physical fitness in children infected with the human immunodeficiency virus: Associations with highly active antiretroviral therapy

AIDS Research and Human Retroviruses

Volumn 29, Issue 1, 2013, Pages 112-120

  Somarriba, Gabriel ^a   Lopez Mitnik, Gabriela ^a   Ludwig, David A ^a   Neri, Daniela ^a   Schaefer, Natasha ^a   Lipshultz, Steven E ^a   Scott, Gwendolyn B ^a   Miller, Tracie L ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY WEIGHT; CD4 LYMPHOCYTE COUNT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FITNESS; HEMOGLOBIN BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIP CIRCUMFERENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PRIORITY JOURNAL; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; VIRUS LOAD; WAIST CIRCUMFERENCE; WEIGHT;

ADOLESCENT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CASE-CONTROL STUDIES; CHILD; FEMALE; HIV INFECTIONS; HUMANS; MALE; MUSCLE STRENGTH; OXYGEN CONSUMPTION; PHYSICAL ENDURANCE; PHYSICAL FITNESS; VIRAL LOAD; YOUNG ADULT;

EID: 84871907016     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2012.0047     Document Type: Article

References (79)

1. Lakka TA and Laaksonen DE: Physical activity in prevention and treatment of the metabolic syndrome. Appl Physiol Nutr Metab 2007;32:76-88.
2. Steele RM, Brage S, Corder K, Wareham NJ, and Ekelund U: Physical activity, cardiorespiratory fitness, and the metabolic syndrome in youth. J Appl Physiol 2008;105:342-351.
3. van Brussel M, van der Net J, Hulzebos E, Helders PJ, and Takken T: The Utrecht approach to exercise in chronic childhood conditions: The decade in review. Pediatr Phys Ther 2011;23:2-14.
4. Pianosi P, Leblanc J, and Almudevar A: Peak oxygen uptake and mortality in children with cystic fibrosis. Thorax 2005; 60:50-54.
5. Davis JA, McBride MG, Chrisant MR, Patil SM, Hanna BD, and Paridon SM: Longitudinal assessment of cardiovascular exercise performance after pediatric heart transplantation. J Heart Lung Transplant 2006;25:626-633.
6. Majnemer A, Shevell M, Law M, et al.: Participation and enjoyment of leisure activities in school-aged children with cerebral palsy. Dev Med Child Neurol 2008;50:751-758.
7. Clark NM, Feldman CH, Evans D, et al.: Managing better: Children, parents, and asthma. Patient Educ Couns 1986;8: 27-38.
8. Herman KM, Craig CL, Gauvin L, and Katzmarzyk PT: Tracking of obesity and physical activity from childhood to adulthood: The Physical Activity Longitudinal Study. Int J Pediatr Obes 2009;4:281-288.
9. Position AHAS. Exercise (Physical Activity) and Children. American Heart Association. http://www.americanheart .org/print-presenter.jhtml?identifier = 4596. Accessed January 15, 2012.
10. Froberg K and Andersen LB: Mini review: physical activity and fitness and its relations to cardiovascular disease risk factors in children. Int J Obes (Lond) 2005;29 Suppl 2: S34-39.
11. Jarfelt M, Kujacic V, Holmgren D, Bjarnason R, and Lannering B: Exercise echocardiography reveals subclinical cardiac dysfunction in young adult survivors of childhood acute lymphoblastic leukemia. Pediatr Blood Cancer 2007;49:835-840.
12. Adamsen L, Quist M, Midtgaard J, et al.: The effect of a multidimensional exercise intervention on physical capacity, well-being and quality of life in cancer patients undergoing chemotherapy. Support Care Cancer 2006;14:116-127.
13. De Caro E, Fioredda F, Calevo MG, et al.: Exercise capacity in apparently healthy survivors of cancer. Arch Dis Child 2006;91:47-51.
14. Adams MJ, Lipsitz SR, Colan SD, et al.: Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. J Clin Oncol 2004;22:3139-3148.
15. Black P, Gutjahr P, and Stopfkuchen H: Physical performance in long-term survivors of acute leukaemia in childhood. Eur J Pediatr 1998;157:464-467.
16. Miller TL, Milton-Miller A, Lopez-Mitnik G, et al.: Exercise capacity in long-term survivors of pediatric cancer. American Society of Clinical Oncology Annual Meeting (Orlando, FL June 2009) (submitted 1/2009, Abstract Control #: 35354, Permanent Abstract ID #: 10026, Accepted as a Discussion Poster in the Pediatric Cancer session on 6/1/09 from 8 to 12 with slide presentation order #13 from 11 to 12 on Level 3, W304E, Poster Board #R14, Level 2 West Hall C). 2009.
17. Somarriba G, Extein J, and Miller TL: Exercise rehabilitation in pediatric cardiomyopathy. Prog Pediatr Cardiol 2008;25: 91-102.
18. Hager A and Hess J: Comparison of health related quality of life with cardiopulmonary exercise testing in adolescents and adults with congenital heart disease. Heart 2005;91:517- 520.
19. Miller TL, Orav EJ, Lipshultz SE, et al.: Risk factors for cardiovascular disease in children infected with human immunodeficiency virus-1. J Pediatr 2008;153:491-497.
20. Sharma TS, Messiah S, Fisher S, Miller TL, and Lipshultz SE: Accelerated cardiovascular disease and myocardial infarction risk in patients with the human immunodeficiency virus. J Cardiometab Syndr 2008;3:93-97.
21. McDonald CL and Kaltman JR: Cardiovascular disease in adult and pediatric HIV/AIDS. J Am Coll Cardiol 2009;54: 1185-1188.
22. Crain MJ, Chernoff MC, Oleske JM, et al.: Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIV. J Infect Dis 2010;202:291-301.
23. Prevention. CfDCa. CDC table for calculated body mass index values for selected heights and weights for ages 2 to 20 years. http://www.cdc.gov/nccdphp/ dnpa/healthyweight/ assessing/bmi/00binaries/bmi-tables.pdf. Accessed February 5, 2012.
24. Koo WW, Hammami M, and Hockman EM: Validation of bone mass and body composition measurements in small subjects with pencil beam dual energy X-ray absorptiometry. J Am Coll Nutr 2004;23:79-84.
25. Margulies L, Horlick M, Thornton JC, Wang J, Ioannidou E, and Heymsfield SB: Reproducibility of pediatric whole body bone and body composition measures by dual-energy X-ray absorptiometry using the GE Lunar Prodigy. J Clin Densitom 2005;8:298-304.
26. National Health and Nutrition Examination Survey III Body Measurements (Anthropometry). http://www.cdc.gov/nchs/ data/nhanes/nhanes3/cdrom/nchs/ manuals/anthro.pdf. Accessed February 1, 2012.
27. Matthews DR, Hosker JP, Rudenski AS, et al.: Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
28. Caldwell MB, Oxtoby MJ, and Simonds RJ: 1994 Revised classification system for human immunodeficiency virus infection in children less than 13 years of age. MMWR CDC Surveill Summ 1994:1-12.
29. Balke B and Ware RW: An experimental study of physical fitness of Air Force personnel. US Armed Forces Med J 1959; 10:675-688.
30. Froelicher VF Jr and Lancaster MC: The prediction of maximal oxygen consumption from a continuous exercise treadmill protocol. Am Heart J 1974;87:445-450.
31. Medicine ACoS. ACSM's Guidelines for Exercise Testing and Prescription, 7th ed. 2006.
32. Mayhew JL, Ball TE, and Bowen JC: Relative muscular endurance performance as a predictor of bench press strength in college men and women. Sports Med Training Rehabil 1992;3:195-201.
33. Castro-Pinero J, Chillon P, Ortega FB, Montesinos JL, Sjostrom M, and Ruiz JR: Criterion-related validity of sitand- reach and modified sit-and-reach test for estimating hamstring flexibility in children and adolescents aged 6-17 years. Int J Sports Med 2009;30:658-662.
34. Sports PsCoPFa: 1985 National School Population Fitness Survey. US Department of Health and Human Services, Public Health Service, Office of the Assistant Secretary for Health, Washington, DC, 1986.
35. Diaconis P and Efron, B. Computer-intensive methods in statistics. Sci Am May 1983:116-130.
36. Miller TL, Somarriba G, Kinnamon DD, Weinberg GA, Friedman LB, and Scott GB: The effect of a structured exercise program on nutrition and fitness outcomes in human immunodeficiency virus-infected children. AIDS Res Hum Retroviruses 2010;26:313-319.
37. Dolan SE, Frontera W, Librizzi J, et al.: Effects of a supervised home-based aerobic and progressive resistance training regimen in women infected with human immunodeficiencyvirus: A randomized trial. Arch Intern Med 2006;166:1225- 1231.
38. Cade WT, Peralta L, and Keyser RE: Aerobic capacity in late adolescents infected with HIV and controls. Pediatr Rehabil 2002;5:161-169.
39. Grinspoon SK, Grunfeld C, Kotler DP, et al.: State of the science conference: Initiative to decrease cardiovascular risk and increase quality of care for patients living with HIV/ AIDS: Executive summary. Circulation 2008;118:198-210.
40. Klein D, Hurley LB, Quesenberry CP Jr, and Sidney S: Do protease inhibitors increase the risk for coronary heart disease in patients with HIV-1 infection? J Acquir Immune Defic Syndr 2002;30:471-477.
41. Miller TL, Grant YT, Almeida DN, Sharma T, and Lipshultz SE: Cardiometabolic disease in human immunodeficiency virus-infected children. J Cardiometab Syndr 2008;3:98-105.
42. Rhoads MP, Lanigan J, Smith CJ, and Lyall EG: Effect of specific ART drugs on lipid changes and the need for lipid management in children with HIV. J Acquir Immune Defic Syndr 2011;57:404-412.
43. Lobelo F, Pate RR, Dowda M, Liese AD, and Daniels SR: Cardiorespiratory fitness and clustered cardiovascular disease risk in U.S. adolescents. J Adolesc Health 2010;47:352- 359.
44. Tanha T, Wollmer P, Thorsson O, et al.: Lack of physical activity in young children is related to higher composite risk factor score for cardiovascular disease. Acta Paediatr 2011;100:717-721.
45. Berry JD, Willis B, Gupta S, et al.: Lifetime risks for cardiovascular disease mortality by cardiorespiratory fitness levels measured at ages 45, 55, and 65 years in men. The Cooper Center Longitudinal Study. J Am Coll Cardiol 2011;57:1604- 1610.
46. Ogalha C, Luz E, Sampaio E, et al.: A randomized, clinical trial to evaluate the impact of regular physical activity on the quality of life, body morphology and metabolic parameters of patients with AIDS in Salvador, Brazil. J Acquir Immune Defic Syndr 2011;57(Suppl 3):S179-185.
47. Fillipas S, Cherry CL, Cicuttini F, Smirneos L, and Holland AE: The effects of exercise training on metabolic and morphological outcomes for people living with HIV: A systematic review of randomised controlled trials. HIV Clin Trials 2010;11:270-282.
48. Yarasheski KE, Cade WT, Overton ET, et al.: Exercise training augments the peripheral insulin-sensitizing effects of pioglitazone in HIV-infected adults with insulin resistance and central adiposity. Am J Physiol Endocrinol Metab 2011;300:E243-251.
49. Raudsepp L and Pall P: Physical growth and fatness as related to physical activity in preadolescent girls. Coll Anthropol 1999;23:53-58.
50. Arpadi SM, Bethel J, Horlick M, et al.: Longitudinal changes in regional fat content in HIV-infected children and adolescents. AIDS 2009;23:1501-1509.
51. Jacobson DL, Patel K, Siberry GK, et al.: Body fat distribution in perinatally HIV-infected and HIV-exposed but uninfected children in the era of highly active antiretroviral therapy: Outcomes from the Pediatric HIV/AIDS Cohort Study (PHACS). Am J Clin Nutr 2011;94:1485-1495.
52. Mokha JS, Srinivasan SR, Dasmahapatra P, et al.: Utility of waist-to-height ratio in assessing the status of central obesity and related cardiometabolic risk profile among normal weight and overweight/obese children: The Bogalusa Heart Study. BMC Pediatr 2010;11.
53. Lake JE, Wohl D, Scherzer R, et al.: Regional fat deposition and cardiovascular risk in HIV infection: The FRAM study. AIDS Care 2011;23:929-938.
54. Mulligan K, Harris DR, Monte D, et al.: Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021. Clin Infect Dis 2010;50: 106-114.
55. Hendricks KM, Willis K, Houser R, and Jones CY: Obesity in HIV-infection: Dietary correlates. J Am Coll Nutr 2006;25: 321-331.
56. Skelton JA, Cook SR, Auinger P, Klein JD, and Barlow SE: Prevalence and trends of severe obesity among US children and adolescents. Acad Pediatr 2009;9:322-329.
57. Must A, Bandini LG, Tybor DJ, Phillips SM, Naumova EN, and Dietz WH: Activity, inactivity, and screen time in relation to weight and fatness over adolescence in girls. Obesity 2007;15:1774-1781.
58. Hager RL: Television viewing and physical activity in children. J Adolesc Health 2006;39:656-661.
59. Tremblay MS, Leblanc AG, Kho ME, et al.: Systematic review of sedentary behaviour and health indicators in school-aged children and youth. Int J Behav Nutr Phys Activity 2011;8:98.
60. Mynarcik D, Wei LX, Komaroff E, Ferris R, McNurlan M, and Gelato M: Chronic loss of subcutaneous adipose tissue in HIV-associated lipodystrophy may not be associated with accelerated apoptosis. J Acquir Immune Defic Syndr 2005;38: 367-371.
61. McComsey GA, Paulsen DM, Lonergan JT, et al.: Improvements in lipoatrophy, mitochondrial DNA levels and fat apoptosis after replacing stavudine with abacavir or zidovudine. AIDS 2005;19:15-23.
62. Vernochet C, Azoulay S, Duval D, Guedj R, Ailhaud G, and Dani C: Differential effect of HIV protease inhibitors on adipogenesis: Intracellular ritonavir is not sufficient to inhibit differentiation. AIDS 2003;17:2177-2180.
63. Walker UA, Setzer B, and Venhoff N: Increased long-term mitochondrial toxicity in combinations of nucleoside analogue reverse-transcriptase inhibitors. AIDS 2002;16:2165- 2173.
64. Carr A, Miller J, Law M, and Cooper DA: A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: Contribution to protease inhibitor-related lipodystrophy syndrome. AIDS 2000;14:F25-32.
65. Domingo P, Matias-Guiu X, Pujol RM, et al.: Subcutaneous adipocyte apoptosis in HIV-1 protease inhibitor-associated lipodystrophy. AIDS 1999;13:2261-2267.
66. Hruz PW, Yan Q, Struthers H, and Jay PY: HIV protease inhibitors that block GLUT4 precipitate acute, decompensated heart failure in a mouse model of dilated cardiomyopathy. FASEB J 2008;22:2161-2167.
67. Dube MP, Parker RA, Tebas P, et al.: Glucose metabolism, lipid, and body fat changes in antiretroviral-naive subjects randomized to nelfinavir or efavirenz plus dual nucleosides. AIDS 2005;19:1807-1818.
68. Mallon PW, Unemori P, Sedwell R, et al.: In vivo, nucleoside reverse-transcriptase inhibitors alter expression of both mitochondrial and lipid metabolism genes in the absence of depletion of mitochondrial DNA. J Infect Dis 2005;191:1686-1696.
69. Bastard JP, Caron M, Vidal H, et al.: Association between altered expression of adipogenic factor SREBP1 in lipoatrophic adipose tissue from HIV-1-infected patients and abnormal adipocyte differentiation and insulin resistance. Lancet 2002;359:1026-1031.
70. Caron M, Auclair M, Sterlingot H, Kornprobst M, and Capeau J: Some HIV protease inhibitors alter lamin A/C maturation and stability, SREBP-1 nuclear localization and adipocyte differentiation. AIDS 2003;17:2437-2444.
71. Rodriguez de la Concepcion ML, Yubero P, Domingo JC, et al.: Reverse transcriptase inhibitors alter uncoupling protein-1 and mitochondrial biogenesis in brown adipocytes. Antivir Ther 2005;10:515-526.
72. Schmiedel J, Jackson S, Schafer J, and Reichmann H: Mitochondrial cytopathies. J Neurol 2003;250:267-277.
73. Elliot DL, Buist NR, Goldberg L, Kennaway NG, Powell BR, and Kuehl KS: Metabolic myopathies: Evaluation by graded exercise testing. Medicine (Baltimore) 1989;68:163-172.
74. Taivassalo T, Jensen TD, Kennaway N, DiMauro S, Vissing J, and Haller RG: The spectrum of exercise tolerance in mitochondrial myopathies: A study of 40 patients. Brain 2003; 126:413-423.
75. Flaherty KR, Wald J, Weisman IM, et al.: Unexplained exertional limitation: Characterization of patients with a mitochondrial myopathy. Am J Respir Crit Care Med 2001; 164:425-432.
76. Duong M, Dumas JP, Buisson M, et al.: Limitation of exercise capacity in nucleoside-treated HIV-infected patients with hyperlactataemia. HIV Med 2007;8:105-111.
77. Roge BT, Calbet JA, Moller K, et al.: Skeletal muscle mitochondrial function and exercise capacity in HIV-infected patients with lipodystrophy and elevated p-lactate levels. AIDS 2002;16:973-982.
78. Hickman TB, Briefel RR, Carroll MD, et al.: Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: Data from the Third National Health and Nutrition Examination Survey. Prev Med 1998;27:879-890.
79. Valerio G, Licenziati MR, Iannuzzi A, et al.: Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy. Nutr Metab Cardiovasc Dis 2006;16:279-284.